SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
4 references·16 citing·32 second hop
Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Subjective effects of 3,4-methylenedioxym…Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Biochemical and histological …3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)3,4-Methylenedioxymethampheta…Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Subjective Reports of the Eff…Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals (1985)Hallucinogenic Amphetamine Se…Psychedelics and Other Psychoplastogens for Treating Mental Illness (2021)Psychedelics and Other Psycho…Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research (2013)Human psychobiology of MDMA o…Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Chronic tolerance to recreati…Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study (2004)Increased intensity of Ecstas…Chronic MDMA (ecstasy) use, cognition and mood (2004)Chronic MDMA (ecstasy) use, c…Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)Methylenedioxymethamphetamine…Altered states: the clinical effects of Ecstasy (2003)Altered states: the clinical …Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users (2003)Acute, sub‐acute and long‐ter…Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans (2000)Psychological and Physiologic…Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects (2000)Human Pharmacology of 3,4-Met…Cognitive performance amongst recreational users of "ecstasy" (2000)Cognitive performance amongst…MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients (1998)MDMA (`ecstasy') consumption …Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits (1998)Cognitive performance in recr…Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low (1997)Mood and cognitive effects of…3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)3,4‐Methylenedioxymethampheta…Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function? (1992)Chronic 3,4-Methylenedioxymet…Profile of mood states (1992)Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)A review of the acute subjective effects of MDMA/ecstasy (2006)Effects of MDMA on sociability and neural response to social threat and social reward (2009)3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial (2018)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity (1998)Memory deficits associated with recreational use of "ecstasy" (MDMA) (1999)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Modeling Sources of Self-report Bias in a Survey of Drug Use Epidemiology (2004)The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (2003)Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study (2010)Clinical applications of hallucinogens: A review. (2016)STAI manual for the State-trait anxiety inventory (1970)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects (2019)The use of analogue scales in rating subjective feelings (1974)The handbook of psychotherapy and behaviour change (1979)Rivermead Behavioural Memory Test (1990)Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users (2000)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study (2012)MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) (2000)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)
this work references cited by second hop

References

  • 19873,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.458 cited
  • 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
  • 1986Subjective Reports of the Effects of MDMA in a Clinical Setting413 cited
  • 1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited

Cited by

  • 19943,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans289 cited
  • 1997Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low283 cited
  • 2000Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans245 cited
  • 2005Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy238 cited
  • 2000Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects234 cited
  • 1998Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits223 cited
  • 2000Cognitive performance amongst recreational users of "ecstasy"218 cited
  • 1998MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients216 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2003Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms199 cited
  • 2003Altered states: the clinical effects of Ecstasy190 cited
  • 2013Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research185 cited
  • 2003Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users171 cited
  • 2004Chronic MDMA (ecstasy) use, cognition and mood169 cited
  • 1992Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?168 cited
  • 2004Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study166 cited
  • 2021Psychedelics and Other Psychoplastogens for Treating Mental Illness166 cited